CD11c controls Herpes Simplex Virus 1 responses to limit virus replication during primary infection

Journal of Virology

Volumn 85, Issue 19, 2011, Pages 9945-9955

  Allen, Sariah J ^a   Mott, Kevin R ^a   Chentoufi, Aziz A ^b   BenMohamed, Lbachir ^b   Wechsler, Steven L ^b   Ballantyne, Christie M ^c,d   Ghiasi, Homayon ^a  

^a Department of Surgery and Regenerative Medicine Institute ^*  (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d HOUSTON METHODIST RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CD11B ANTIGEN; CD83 ANTIGEN; GAMMA INTERFERON; GLYCOPROTEIN P 15095; MESSENGER RNA;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIGEN EXPRESSION; ARTICLE; CD8+ T LYMPHOCYTE; CELL POPULATION; CONTROLLED STUDY; DENDRITIC CELL; EYE DISEASE; EYE INFECTION; HERPES SIMPLEX; HERPES SIMPLEX KERATITIS; HERPES SIMPLEX VIRUS 1; INNATE IMMUNITY; LATENT PERIOD; MOUSE; NONHUMAN; PRIMARY INFECTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SPLEEN; SURVIVAL RATE; TEAR FILM; TRIGEMINUS GANGLION; VIRUS DETECTION; VIRUS REPLICATION;

ANIMALS; ANTIGENS, CD11C; CD8-POSITIVE T-LYMPHOCYTES; CYTOKINES; DENDRITIC CELLS; DISEASE MODELS, ANIMAL; EYE; EYE INFECTIONS; HERPES SIMPLEX; HERPESVIRUS 1, HUMAN; MICE; MICE, INBRED C57BL; RODENT DISEASES; SURVIVAL ANALYSIS; TRIGEMINAL GANGLION; VIRUS REPLICATION;

ANIMALIA; HUMAN HERPESVIRUS 1; MUS;

EID: 80053968744     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.05208-11     Document Type: Article

References (69)

1. Allen, S. J., et al. 2011. The role of LAT in increased CD8+ T cell exhaustion in trigeminal ganglia of mice latently infected with herpes simplex virus type 1. J. Virol. 85:4184-4197.
2. Auslander, B. A., F. M. Biro, and S. L. Rosenthal. 2005. Genital herpes in adolescents. Semin. Pediatr. Infect. Dis. 16:24-30.
3. Barron, B. A., et al. 1994. Herpetic Eye Disease Study. A controlled trial of oral acyclovir for herpes simplex stromal keratitis. Ophthalmology 101:1871-1882.
4. Behrens, G., et al. 2004. Helper T cells, dendritic cells and CTL immunity. Immunol. Cell Biol. 82:84-90.
5. Bosnjak, L., et al. 2005. Herpes simplex virus infection of human dendritic cells induces apoptosis and allows cross-presentation via uninfected dendritic cells. J. Immunol. 174:2220-2227.
6. Brown, D. C., A. B. Nesburn, J. S. Nauheim, D. Pavan-Langston, and H. E. Kaufman. 1968. Recurrent herpes simplex conjunctivitis. Arch. Ophthalmol. 79:733-735.
7. Bullard, D. C., X. Hu, J. E. Adams, T. R. Schoeb, and S. R. Barnum. 2007. p150/95 (CD11c/CD18) expression is required for the development of experimental autoimmune encephalomyelitis. Am. J. Pathol. 170:2001-2008.
8. Cella, M., et al. 1999. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat. Med. 5:919-923.
9. Colonna, M., B. Pulendran, and A. Iwasaki. 2006. Dendritic cells at the host-pathogen interface. Nat. Immunol. 7:117-120.
10. Corey, L. 1994. The current trend in genital herpes. Progress in prevention. Sex. Transm. Dis. 21:S38-S44.
11. Dawson, C. R., and B. Togni. 1976. Herpes simplex eye infections: clinical manifestations, pathogenesis and management. Surv. Ophthalmol. 21:121-135.
12. Dix, R. D. 1987. Prospects for a vaccine against herpes simplex virus types 1 and 2. Prog. Med. Virol. 34:89-128.
13. Fraser, N. W., and T. Valyi-Nagy. 1993. Viral, neuronal and immune factors which may influence herpes simplex virus (HSV) latency and reactivation. Microb. Pathog. 15:83-91.
14. Fujimoto, Y., and T. F. Tedder. 2006. CD83: a regulatory molecule of the immune system with great potential for therapeutic application. J. Med. Dent. Sci. 53:85-91.
15. Fujimoto, Y., et al. 2002. CD83 expression influences CD4+ T cell development in the thymus. Cell 108:755-767.
16. Geissmann, F., S. Jung, and D. R. Littman. 2003. Blood monocytes consist of two principal subsets with distinct migratory properties. Immunity 19:71-82.
17. Ghiasi, H., S. Bahri, A. B. Nesburn, and S. L. Wechsler. 1995. Protection against herpes simplex virus-induced eye disease after vaccination with seven individually expressed herpes simplex virus 1 glycoproteins. Invest. Ophthalmol. Vis. Sci. 36:1352-1360.
18. Ghiasi, H., S. Cai, A. B. Nesburn, and S. L. Wechsler. 1996. Vaccination with herpes simplex virus type 1 glycoprotein K impairs clearance of virus from the trigeminal ganglia resulting in chronic infection. Virology 224:330-333.
19. Ghiasi, H., R. Kaiwar, S. Slanina, A. B. Nesburn, and S. L. Wechsler. 1994. Expression and characterization of baculovirus expressed herpes simplex virus type 1 glycoprotein L. Arch. Virol. 138:199-212.
20. Ghiasi, H., et al. 2002. Infection of BALB/c mice with a herpes simplex virus type 1 recombinant virus expressing IFN-g driven by the LAT promoter. Virology 302:144-154.
21. Ghiasi, H., G. Perng, A. B. Nesburn, and S. L. Wechsler. 1999. Either a CD4(+) or CD8(+) T cell function is sufficient for clearance of infectious virus from trigeminal ganglia and establishment of herpes simplex virus type 1 latency in mice. Microb. Pathog. 27:387-394.
22. Guerau-de-Arellano, M., J. Alroy, D. Bullard, and B. T. Huber. 2005. Aggravated Lyme carditis in CD11a-/- and CD11c-/- mice. Infect. Immun. 73:7637-7643.
23. Hirano, N., et al. 2006. Engagement of CD83 ligand induces prolonged expansion of CD8+ T cells and preferential enrichment for antigen specificity. Blood 107:1528-1536.
24. John-Philip, B., and D. J. Carr. 2005. Transfection of Muller cells with type I interferon transgenes: resistance to HSV-1 infection. Methods Mol. Med. 116:221-232.
25. Jugovic, P., A. M. Hill, R. Tomazin, H. Ploegh, and D. C. Johnson. 1998. Inhibition of major histocompatibility complex class I antigen presentation in pig and primate cells by herpes simplex virus type 1 and 2 ICP47. J. Virol. 72:5076-5084.
26. Kobelt, D., M. Lechmann, and A. Steinkasserer. 2003. The interaction between dendritic cells and herpes simplex virus-1. Curr. Top. Microbiol. Immunol. 276:145-161.
27. Koelle, D. M., and H. Ghiasi. 2005. Prospects for developing an effective vaccine against ocular herpes simplex virus infection. Curr. Eye Res. 30:929-942.
28. Kohrgruber, N., et al. 1999. Survival, maturation, and function of CD11c- and CD11c+ peripheral blood dendritic cells are differentially regulated by cytokines. J. Immunol. 163:3250-3259.
29. Kretschmer, B., K. Luthje, S. Schneider, B. Fleischer, and M. Breloer. 2009. Engagement of CD83 on B cells modulates B cell function in vivo. J. Immunol. 182:2827-2834.
30. Kurt-Jones, E. A., et al. 2004. Herpes simplex virus 1 interaction with Tolllike receptor 2 contributes to lethal encephalitis. Proc. Natl. Acad. Sci. U. S. A. 101:1315-1320.
31. Kurts, C. 2008. CD11c: not merely a murine DC marker, but also a useful vaccination target. Eur. J. Immunol. 38:2072-2075.
32. Lan, Z., et al. 2010. Prevention of chronic renal allograft rejection by soluble CD83. Transplantation 90:1278-1285.
33. Leib, D. A., et al. 1999. Interferons regulate the phenotype of wild-type and mutant herpes simplex viruses in vivo. J. Exp. Med. 189:663-672.
34. Liesegang, T. J. 2001. Herpes simplex virus epidemiology and ocular importance. Cornea 20:1-13.
35. Mikloska, Z., L. Bosnjak, and A. L. Cunningham. 2001. Immature monocyte-derived dendritic cells are productively infected with herpes simplex virus type 1. J. Virol. 75:5958-5964.
36. Mott, K. R., and H. Ghiasi. 2008. Role of dendritic cells in enhancement of herpes simplex virus type 1 latency and reactivation in vaccinated mice. Clin. Vaccine Immunol. 15:1859-1867.
37. Mott, K. R., et al. 2007. The corneas of naive mice contain both CD4+ and CD8+ T cells. Mol. Vis. 13:1802-1812.
38. Mott, K. R., G. C. Perng, Y. Osorio, K. G. Kousoulas, and H. Ghiasi. 2007. A recombinant herpes simplex virus type 1 expressing two additional copies of gK is more pathogenic than wild-type virus in two different strains of mice. J. Virol. 81:12962-12972.
39. Mott, K. R., D. UnderHill, S. L. Wechsler, and H. Ghiasi. 2008. Lymphoidrelated CD11c+ CD8a+ dendritic cells are involved in enhancing HSV-1 latency. J. Virol. 82:9870-9879.
40. Mott, K. R., D. Underhill, S. L. Wechsler, T. Town, and H. Ghiasi. 2009. A role for the JAK-STAT1 pathway in blocking replication of HSV-1 in dendritic cells and macrophages. Virol. J. 6:56.
41. Muller, D. B., M. J. Raftery, A. Kather, T. Giese, and G. Schonrich. 2004. Frontline: induction of apoptosis and modulation of c-FLIPL and p53 in immature dendritic cells infected with herpes simplex virus. Eur. J. Immunol. 34:941-951.
42. Noisakran, S., and D. J. Carr. 2001. Type I interferons and herpes simplex virus infection: a naked DNA approach as a therapeutic option? Immunol. Res. 24:1-11.
43. Novak, N., and W. M. Peng. 2005. Dancing with the enemy: the interplay of herpes simplex virus with dendritic cells. Clin. Exp. Immunol. 142:405-410.
44. Oh, J. O., S. J. Kimura, H. B. Ostler, C. R. Dawson, and G. Smolin. 1976. Oculogenital transmission of type 2 herpes simplex virus in adults. Surv. Ophthalmol. 21:106-109.
45. Osorio, Y., J. Cohen, and H. Ghiasi. 2004. Improved protection from primary ocular HSV-1 infection and establishment of latency using multigenic DNA vaccines. Invest. Ophthalmol. Vis. Sci. 45:506-514.
46. Osorio, Y., and H. Ghiasi. 2003. Comparison of adjuvant efficacy of herpes simplex virus type 1 recombinant viruses expressing TH1 and TH2 cytokine genes. J. Virol. 77:5774-5783.
47. Pavan-Langston, D. 1983. Ocular viral infections. Med. Clin. North Am. 67:973-990.
48. Perng, G. C., et al. 1994. The latency-associated transcript gene of herpes simplex virus type 1 (HSV-1) is required for efficient in vivo spontaneous reactivation of HSV-1 from latency. J. Virol. 68:8045-8055.
49. Prechtel, A. T., et al. 2005. Infection of mature dendritic cells with herpes simplex virus type 1 dramatically reduces lymphoid chemokine-mediated migration. J. Gen. Virol. 86:1645-1657.
50. Probst, H. C., et al. 2005. Histological analysis of CD11c-DTR/GFP mice after in vivo depletion of dendritic cells. Clin. Exp. Immunol. 141:398-404.
51. Pulendran, B., H. Tang, and T. L. Denning. 2007. Division of labor, plasticity, and crosstalk between dendritic cell subsets. Curr. Opin. Immunol. 12:12.
52. Roberts, C. M., J. R. Pfister, and S. J. Spear. 2003. Increasing proportion of herpes simplex virus type 1 as a cause of genital herpes infection in college students. Sex. Transm. Dis. 30:797-800.
53. Schultz, U., B. Kaspers, and P. Staeheli. 2004. The interferon system of non-mammalian vertebrates. Dev. Comp. Immunol. 28:499-508.
54. Siegal, F. P., et al. 1999. The nature of the principal type 1 interferonproducing cells in human blood. Science 284:1835-1837.
55. Singh, A. E., et al. 2005. Herpes simplex virus seroprevalence and risk factors in 2 Canadian sexually transmitted disease clinics. Sex. Transm. Dis. 32:95-100.
56. Steinman, R. M., and H. Hemmi. 2006. Dendritic cells: translating innate to adaptive immunity. Curr. Top. Microbiol. Immunol. 311:17-58.
57. Stevens, J. G. 1989. Human herpesviruses: a consideration of the latent state. Microbiol. Rev. 53:318-332.
58. Su, Y. H., J. E. Oakes, and R. N. Lausch. 1990. Ocular avirulence of a herpes simplex virus type 1 strain is associated with heightened sensitivity to alpha/beta interferon. J. Virol. 64:2187-2192.
59. Tuting, T., et al. 1999. Dendritic cell-based genetic immunization in mice with a recombinant adenovirus encoding murine TRP2 induces effective anti-melanoma immunity. J. Gene Med. 1:400-406.
60. Tze, L. E., et al. 2011. CD83 increases MHC II and CD86 on dendritic cells by opposing IL-10-driven MARCH1-mediated ubiquitination and degradation. J. Exp. Med. 208:149-165.
61. Vandevenne, P., C. Sadzot-Delvaux, and J. Piette. 2010. Innate immune response and viral interference strategies developed by human herpesviruses. Biochem. Pharmacol. 80:1955-1972.
62. Welsh, R. M., Jr. 1978. Mouse natural killer cells: induction specificity, and function. J. Immunol. 121:1631-1635.
63. White, A. L., et al. 2010. Ligation of CD11c during vaccination promotes germinal centre induction and robust humoral responses without adjuvant. Immunology 131:141-151.
64. Wu, H., et al. 2009. Functional role of CD11c+ monocytes in atherogenesis associated with hypercholesterolemia. Circulation 119:2708-2717.
65. Wu, H., et al. 2004. Deficiency of CD11b or CD11d results in reduced staphylococcal enterotoxin-induced T cell response and T cell phenotypic changes. J. Immunol. 173:297-306.
66. York, I. A., et al. 1994. A cytosolic herpes simplex virus protein inhibits antigen presentation to CD8+ T lymphocytes. Cell 77:525-535.
67. Zhou, L. J., R. Schwarting, H. M. Smith, and T. F. Tedder. 1992. A novel cell-surface molecule expressed by human interdigitating reticulum cells, Langerhans cells, and activated lymphocytes is a new member of the Ig superfamily. J. Immunol. 149:735-742.
68. Zhou, L. J., and T. F. Tedder. 1995. Human blood dendritic cells selectively express CD83, a member of the immunoglobulin superfamily. J. Immunol. 154:3821-3835.
69. Zinser, E., N. Turza, and A. Steinkasserer. 2004. CNI-1493 mediated suppression of dendritic cell activation in vitro and in vivo. Immunobiology 209:89-97.